Conditions

close

result 18347 件

FullText URL K0005673_abstract_review.pdf K0005673_summary.pdf K0005673_fulltext.pdf
Author Ako, Soichiro|
Published Date 2018-03-23
Content Type Thesis or Dissertation
Grant Number 甲第5673号
Granted Date 2018-03-23
Thesis Type Doctor of Philosophy in Medical Science
Grantor 岡山大学
language English
FullText URL K0005670_abstract_review.pdf K0005670_suumary.pdf K0005670_fulltext.pdf
Author Nakano, Yumiko|
Published Date 2018-03-23
Content Type Thesis or Dissertation
Grant Number 甲第5670号
Granted Date 2018-03-23
Thesis Type Doctor of Philosophy in Medical Science
Grantor 岡山大学
language English
FullText URL K0005669_fulltext.pdf K0005669_fig.pdf K0005669_abstract_review.pdf K0005669_summary.pdf
Author Fujiwara, Masaki|
Published Date 2018-03-23
Content Type Thesis or Dissertation
Grant Number 甲第5669号
Granted Date 2018-03-23
Thesis Type Doctor of Philosophy in Medical Science
Grantor 岡山大学
language English
FullText URL K0005667_abstract_review.pdf K0005667_summary.pdf K0005667_fulltext.pdf
Author Zhong, Hui|
Published Date 2018-03-23
Content Type Thesis or Dissertation
Grant Number 甲第5667号
Granted Date 2018-03-23
Thesis Type Doctor of Philosophy in Medical Science
Grantor 岡山大学
language English
FullText URL K0005663_abstract_review.pdf K0005663_summary.pdf K0005663_fulltext.pdf
Author Uotani, Koji|
Published Date 2018-03-23
Content Type Thesis or Dissertation
Grant Number 甲第5663号
Granted Date 2018-03-23
Thesis Type Doctor of Philosophy in Medical Science
Grantor 岡山大学
language English
FullText URL K0005658_abstract_review.pdf K0005658_summary.pdf K0005658_fulltext.pdf
Author Kojima, Soichi|
Published Date 2018-03-23
Content Type Thesis or Dissertation
Grant Number 甲第5658号
Granted Date 2018-03-23
Thesis Type Doctor of Philosophy in Medical Science
Grantor 岡山大学
language English
FullText URL K0005650_abstract_review.pdf K0005650_summary.pdf K0005650_fulltext.pdf
Author Kuroda, Kosuke|
Published Date 2018-03-23
Content Type Thesis or Dissertation
Grant Number 甲第5650号
Granted Date 2018-03-23
Thesis Type Doctor of Philosophy in Medical Science
Grantor 岡山大学
language English
FullText URL K0005649_abstract_review.pdf K0005649_summary.pdf K0005649_fulltext.pdf
Author Ninomiya, Takayuki|
Published Date 2018-03-23
Content Type Thesis or Dissertation
Grant Number 甲第5649号
Granted Date 2018-03-23
Thesis Type Doctor of Philosophy in Medical Science
Grantor 岡山大学
language English
FullText URL K0005648_abstract_review.pdf K0005648_summary.pdf K0005648_fulltext.pdf
Author Tatebe, Noriko|
Published Date 2018-03-23
Content Type Thesis or Dissertation
Grant Number 甲第5648号
Granted Date 2018-03-23
Thesis Type Doctor of Philosophy in Medical Science
Grantor 岡山大学
language English
FullText URL K0005646_abstract_review.pdf K0005646_fulltext.pdf K0005646_fulltext.pdf
Author Ida, Jun|
Published Date 2018-03-23
Content Type Thesis or Dissertation
Grant Number 甲第5646号
Granted Date 2018-03-23
Thesis Type Doctor of Philosophy in Medical Science
Grantor 岡山大学
language English
FullText URL MolGenetGenomics20180516.pdf
Author Sawada, Takahiro| Eguchi, Miho| Asaki, Seiya| Kashiwagi, Ryota| Shimomura, Kousuke| Taguchi, Fumiko| Matsui, Hidenori| Yamamoto, Mikihiro| Noutoshi, Yoshiteru| Toyoda, Kazuhiro| Ichinose, Yuki|
Keywords Flagella motility MexEF-OprN Multidrug efflux pump transporter N-Acyl-homoserine lactone Quorum sensing
Note This is an Accepted Manuscript of an article published by Springer Nature 2018 |
Published Date 2018-03-16
Publication Title Molecular Genetics and Genomics
Volume volume293
Issue issue4
Publisher Springer
Start Page 1
End Page 11
ISSN 16174615
NCID AA11547886
Content Type Journal Article
language English
OAI-PMH Set 岡山大学
Copyright Holders https://creativecommons.org/licenses/by-nc-nd/4.0/deed.ja
File Version author
PubMed ID 29549432
DOI 10.1007/s00438-018-1430-9
Web of Science KeyUT 000437440800011
Related Url isVersionOf https://doi.org/10.1007/s00438-018-1430-9
JaLCDOI 10.18926/AMO/55864
FullText URL 72_2_203.pdf
Author Sonekatsu, Mayumi| Sonohata, Motoki| Kitajima, Masaru| Kawano, Shunsuke| Mawatari, Masaaki|
Abstract In the article by Sonekatsu M et al. entitled “Total Hip Arthroplasty for Patients with Residual Poliomyelitis at a Mean Eight Years of Follow-up”, which appeared in the February 2018 issue, Vol.72, No.1, pp17-22, following corrections should be listed. Editorial Office sincerely apologizes for making mistakes in the previous galley proof, therefore republish a corrected version.
Amo Type Erratum with Corrected and Republished Article
Publication Title Acta Medica Okayama
Published Date 2018-04
Volume volume72
Issue issue2
Publisher Okayama University Medical School
Start Page 203
End Page 210
ISSN 0386-300X
NCID AA00508441
Content Type Journal Article
language English
Copyright Holders CopyrightⒸ 2018 by Okayama University Medical School
File Version publisher
Refereed True
PubMed ID 29674772
Related Url replaces http://doi.org/10.18926/AMO/55658
JaLCDOI 10.18926/AMO/55863
FullText URL 72_2_197_n.pdf
Author Takase, Ken| Kada, Akiko| Iwasaki, Hiromi| Yoshida, Isao| Sawamura, Morio| Yoshio, Nobuyuki| Yoshida, Shinichiro| Iida, Hiroatsu| Otsuka, Maki| Takafuta, Toshiro| Ogata, Yuko| Suehiro, Youko| Hirabayashi, Yukio| Hishita, Terutoshi| Yoshida, Chikamasa| Ito, Takuo| Hidaka, Michihiro| Tsutsumi, Ikuyo| Saito, Akiko M.| Nagai, Hirokazu|
Abstract Standard therapy for idiopathic thrombocytopenic purpura (ITP) has not been established. We are conducting a multicenter, prospective trial to determine the efficacy and safety of short-term, high-dose dexamethasone therapy in ITP patients aged 18-80 years with platelet counts of <20, 000 /μL, or with <50, 000/ μL and bleeding symptoms. The primary endpoints of this trial are the proportion of responses (complete plus partial response) on day 180 (day 46+180) after the completion of the 46-day high-dose dexamethasone therapy. The results of this investigation of the effectiveness and safety of this regimen will be essential for the establishment of standard therapy for ITP.
Keywords idiopathic thrombocytopenic purpura short-term high-dose dexamethasone therapy open-label single-arm trial
Amo Type Clinical Study Protocol
Publication Title Acta Medica Okayama
Published Date 2018-04
Volume volume72
Issue issue2
Publisher Okayama University Medical School
Start Page 197
End Page 201
ISSN 0386-300X
NCID AA00508441
Content Type Journal Article
language English
Copyright Holders CopyrightⒸ 2018 by Okayama University Medical School
File Version publisher
Refereed True
PubMed ID 29674771
JaLCDOI 10.18926/AMO/55862
FullText URL 72_2_193.pdf
Author Shioji, Naohiro| Kanazawa, Tomoyuki| Iwasaki, Tatsuo| Shimizu, Kazuyoshi| Suemori, Tomohiko| Kawase, Hirokazu| Kimura, Satoshi| Kuroe, Yasutoshi| Morimatsu, Hiroshi|
Abstract We will investigate the incidence of postoperative pulmonary complications (PPCs) with the prophylactic use of a high-flow nasal cannula (HFNC) after pediatric cardiac surgery. Children < 48 months old with congenital heart disease for whom cardiac surgery is planned will be included. The HFNC procedure will be commenced just after extubation, at a flow rate of 2 L/kg/min with adequate oxygen concentration to achieve target oxygen saturation ≥ 94%. This study will reveal the prevalence of PPCs after pediatric cardiac surgery with the prophylactic use of HFNC.
Keywords high-flow nasal cannula postoperative pulmonary complications pediatric cardiac surgery congenital heart disease
Amo Type Clinical Study Protocol
Publication Title Acta Medica Okayama
Published Date 2018-04
Volume volume72
Issue issue2
Publisher Okayama University Medical School
Start Page 193
End Page 196
ISSN 0386-300X
NCID AA00508441
Content Type Journal Article
language English
Copyright Holders CopyrightⒸ 2018 by Okayama University Medical School
File Version publisher
Refereed True
PubMed ID 29674770
JaLCDOI 10.18926/AMO/55861
FullText URL 72_2_189.pdf
Author Nakao, Shinichiro| Hagiya, Hideharu| Kimura, Keigo| Mitsui, Tomomi| Oyama, Akane| Hongyo, Kazuhiro| Takahashi, Yusuke| Nakagami, Futoshi| Tomono, Kazunori| Rakugi, Hiromi|
Abstract A 65-year-old Japanese man with bilateral carotid atherosclerosis presented with right neck pain and fever. Contrast-enhanced computed tomography suggested carotid arteritis, and carotid ultrasonography showed an unstable plaque. The patient developed a cerebral embolism, causing a transient ischemic attack. Helicobacter cinaedi was detected in blood culture, and H. cinaedi-associated carotid arteritis was diagnosed. Empirical antibiotic therapy was administered for 6 weeks. After readmission for recurrent fever, he was treated another 8 weeks. Although the relationship between H. cinaedi infection and atherosclerosis development remains unclear, the atherosclerotic changes in our patient’s carotid artery might have been attributable to H. cinaedi infection.
Keywords atherosclerosis bacteremia bacterial translocation Helicobacter cinaedi vascular infection
Amo Type Case Report
Publication Title Acta Medica Okayama
Published Date 2018-04
Volume volume72
Issue issue2
Publisher Okayama University Medical School
Start Page 189
End Page 192
ISSN 0386-300X
NCID AA00508441
Content Type Journal Article
language English
Copyright Holders CopyrightⒸ 2018 by Okayama University Medical School
File Version publisher
Refereed True
PubMed ID 29674769
JaLCDOI 10.18926/AMO/55860
FullText URL 72_2_185.pdf
Author Morizane, Shin| Sugimoto, Saeko| Motoki, Takayuki| Katayama, Norihisa| Omori, Masako| Iwatsuki, Keiji|
Abstract Psoriasis is a common chronic inflammatory skin disorder that is characterized by scaly, erythematous, sharply demarcated plaques. The treatment for psoriasis has dramatically changed over the last 10 years with the introduction of biologics. However, the risk of cancer induced by biologics for psoriasis has not been fully analyzed, since these agents have such a short history of use. Here we report the case of a 74-year-old woman with psoriasis vulgaris and psoriatic arthritis complicated by breast cancer after systemic treatments including etretinate, cyclosporine, methotrexate, adalimumab, and ustekinumab.
Keywords psoriasis systemic therapy biologics malignancy
Amo Type Case Report
Publication Title Acta Medica Okayama
Published Date 2018-04
Volume volume72
Issue issue2
Publisher Okayama University Medical School
Start Page 185
End Page 187
ISSN 0386-300X
NCID AA00508441
Content Type Journal Article
language English
Copyright Holders CopyrightⒸ 2018 by Okayama University Medical School
File Version publisher
Refereed True
PubMed ID 29674768
JaLCDOI 10.18926/AMO/55859
FullText URL 72_2_181.pdf
Author Tsuboi, Chika| Naito, Hiromichi| Hagioka, Shingo| Hanafusa, Hiroaki| Hirayama, Takahiro| Kosaki, Yoshinori| Iida, Atsuyoshi| Yumoto, Tetsuya| Tsukahara, Kohei| Morimoto, Naoki| Nakao, Atsunori|
Abstract The primary toxicity of hydrogen peroxide results from its interaction with catalase, which liberates water and oxygen. We report the case of a 14-year-old Japanese girl with portal venous gas that was caused by oxygen liberated from intentionally ingested hydrogen peroxide. Although she had a past history of atrial septal defect, recovery without cardiac or neurological sequelae was achieved using hyperbaric oxygen therapy. Emergency physicians must be aware of the danger of liberated oxygen due to hydrogen peroxide ingestion.
Keywords air embolism ASD breaching agent HBO intoxication
Amo Type Case Report
Publication Title Acta Medica Okayama
Published Date 2018-04
Volume volume72
Issue issue2
Publisher Okayama University Medical School
Start Page 181
End Page 183
ISSN 0386-300X
NCID AA00508441
Content Type Journal Article
language English
Copyright Holders CopyrightⒸ 2018 by Okayama University Medical School
File Version publisher
Refereed True
PubMed ID 29674767
JaLCDOI 10.18926/AMO/55858
FullText URL 72_2_175.pdf
Author Hirata, Takeshi| Hanamoto, Masanori| Ogura, Kazuma| Hayashi, Nobuki| Takamura, Kosuke| Edamura, Kohei| Ebara, Shin| Saika, Takashi|
Abstract There is no standard second-line or salvage treatment for advanced urothelial carcinoma (UC). Here we investigated the efficacy and safety of gemcitabine, cisplatin, and paclitaxel (GCP) combination chemotherapy as salvage chemotherapy for advanced UC. We retrospectively analyzed the cases of 23 patients with advanced UC who showed progression or recurrence after cisplatin-based chemotherapy. Gemcitabine (1000 mg/m2), and paclitaxel (80 mg/m2) were administered on days 1 and 8. Cisplatin (70 mg/m2) was administered on day 1. The 3-week cycle regimen was repeated until disease progression if it had no intolerable toxicity. The overall response rate was 61% (95%CI, 41-78%). The median overall survival and progression-free survival times were 14 months and 5.5 months, respectively. Of the already known risk factors of chemotherapy for advanced UC, only the performance status was a prognostic factor for OS. Overall, 16 of the 23 patients (70%) experienced grade 3/4 toxicities, and no fatal adverse events were observed. GCP therapy was a promising option as second-line or salvage therapy for advanced UC.
Keywords urothelial carcinoma gemcitabine cisplatin paclitaxel second-line salvage
Amo Type Original Article
Publication Title Acta Medica Okayama
Published Date 2018-04
Volume volume72
Issue issue2
Publisher Okayama University Medical School
Start Page 175
End Page 179
ISSN 0386-300X
NCID AA00508441
Content Type Journal Article
language English
Copyright Holders CopyrightⒸ 2018 by Okayama University Medical School
File Version publisher
Refereed True
PubMed ID 29674766
JaLCDOI 10.18926/AMO/55857
FullText URL 72_2_165.pdf
Author Yoshida, Aki| Fujiwara, Tomohiro| Uotani, Koji| Morita, Takuya| Kiyono, Masahiro| Yokoo, Suguru| Hasei, Joe| Nakata, Eiji| Kunisada, Toshiyuki| Ozaki, Toshifumi|
Abstract Although there is considerable evidence indicating that the dysregulation of microRNAs (miRNAs) in malignant tumors plays a role in tumor development, the overall function of miRNAs and their clinicopathological significance are not well understood. In this retrospective analysis of 45 biopsy specimens from osteosarcoma (OS) patients, we investigated the functional and clinical significance of miR-25-3p in OS, which we previously identified as a highly expressed miRNA in OS patients’ serum. We observed that miR-25-3p dysregulation in human OS tissues was negatively correlated with the clinical prognosis, whereas the expression level of its target gene, Dickkopf WNT Signaling Pathway Inhibitor 3 (DKK3), was positively correlated with the clinical prognosis. Endogenous miR-25-3p upregulation promoted tumor growth, invasion, and drug resistance, which was consistent with DKK3 silencing in OS cells. In addition, secretory miR-25-3p was embedded in tumor-derived exosomes, where it promoted capillary formation and the invasion of vascular endothelial cells. Overall, our results show that miR-25-3p has intracellular and extracellular oncogenic functions as well as clinicopathological relevance in OS, indicating its potential as a novel diagnostic and therapeutic tool for the clinical management of this disease.
Keywords microRNA circulating microRNA osteosarcoma prognosis
Amo Type Original Article
Publication Title Acta Medica Okayama
Published Date 2018-04
Volume volume72
Issue issue2
Publisher Okayama University Medical School
Start Page 165
End Page 174
ISSN 0386-300X
NCID AA00508441
Content Type Journal Article
language English
Copyright Holders CopyrightⒸ 2018 by Okayama University Medical School
File Version publisher
Refereed True
PubMed ID 29674765
JaLCDOI 10.18926/AMO/55856
FullText URL 72_2_153.pdf
Author Kumashiro, Masayuki| Kataoka, Takahiro| Yokota, Shinobu| Nakagawa, Shinobu| Otsuki, Keisuke| Miyake, Nobuyuki| Osumi, Shinji| Yamaoka, Kiyonori|
Abstract We examined the effects of a reduced exposure dose on the quality of images from an angiography device augmented with a noise reduction algorithm. Before its clinical application, we compared the diameter of the discrimination limit of the hole with that in the conventional method by a visual evaluation with a contrast-detail (C-D) phantom imaged using the target dose. Based on the results, a reducible dose was determined and applied clinically. The sample population consisted of patients being followed up after percutaneous coronary intervention (PCI) for coronary artery disease; we evaluated the effects of the exposure reduction on image quality. A significant dose reduction was observed by the noise-reduction method compared to the conventional method; the radiation dose to the flat panel detector (FPD) could be reduced to 70 nGy per frame. Clinically, a dose reduction of approx. 40% was obtained while maintaining image quality almost equal to that of the conventional method.
Keywords image quality radiation dose noise reduction percutaneous coronary intervention contrast-detail phantom
Amo Type Original Article
Publication Title Acta Medica Okayama
Published Date 2018-04
Volume volume72
Issue issue2
Publisher Okayama University Medical School
Start Page 153
End Page 164
ISSN 0386-300X
NCID AA00508441
Content Type Journal Article
language English
Copyright Holders CopyrightⒸ 2018 by Okayama University Medical School
File Version publisher
Refereed True
PubMed ID 29674764